LifeStance Health Group, Inc. Operating Cash Flow
LifeStance Health Group, Inc. (LFST) reported Operating Cash Flow of $133.02 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06
- LifeStance Health Group, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $99.91M, a 55.15% increase year-over-year.
- LifeStance Health Group, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $33.11M.
- LifeStance Health Group, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $57.56M, a 7.63% decline year-over-year.
- LifeStance Health Group, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $27.29M, a 20.09% increase year-over-year.
- LifeStance Health Group, Inc. net cash provided by (used in) operating activities for fiscal 2025 was $146.15M, a 36.26% increase from fiscal 2024.
- LifeStance Health Group, Inc. net cash provided by (used in) operating activities for fiscal 2024 was $107.26M.
- LifeStance Health Group, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$16.88M, a 131.98% decline from fiscal 2022.
- LifeStance Health Group, Inc. net cash provided by (used in) operating activities for fiscal 2022 was $52.79M, a 460.39% increase from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 4 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $99.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $133.02M 10-Q · filed 2026-08-06 | $190.58M derived: sum of 3 quarters · filed 2026-08-06 | $217.87M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $33.11M 10-Q · filed 2026-05-07 | $90.67M derived: sum of 2 quarters · filed 2026-05-07 | $117.96M derived: sum of 3 quarters · filed 2026-05-07 | $182.35M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $57.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $84.85M derived: sum of 2 quarters · filed 2026-02-25 | $149.24M derived: sum of 3 quarters · filed 2026-08-06 | $146.15M 10-K · filed 2026-02-25 | |
| 2025-09-30 | $27.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $91.68M derived: sum of 2 quarters · filed 2026-08-06 | $88.59M 10-Q · filed 2025-11-06 | $150.91M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $64.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $61.30M 10-Q · filed 2026-08-06 | $123.62M derived: sum of 3 quarters · filed 2026-08-06 | $146.34M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | -$3.09M 10-Q · filed 2026-05-07 | $59.22M derived: sum of 2 quarters · filed 2026-05-07 | $81.95M derived: sum of 3 quarters · filed 2026-05-07 | $126.01M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $62.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $85.04M derived: sum of 2 quarters · filed 2026-02-25 | $129.10M derived: sum of 3 quarters · filed 2026-02-25 | $107.26M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $22.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $66.78M derived: sum of 2 quarters · filed 2025-11-06 | $44.94M 10-Q · filed 2025-11-06 | $61.74M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2024-06-30 | $44.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $22.22M 10-Q · filed 2025-08-07 | $39.02M derived: sum of 3 quarters · filed 2026-02-25 | $13.66M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2024-03-31 | -$21.84M 10-Q · filed 2025-05-07 | -$5.04M derived: sum of 2 quarters · filed 2026-02-25 | -$30.40M derived: sum of 3 quarters · filed 2026-02-25 | -$30.83M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2023-12-31 | $16.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$8.56M derived: sum of 2 quarters · filed 2026-02-25 | -$8.99M derived: sum of 3 quarters · filed 2026-02-25 | -$16.88M 10-K · filed 2026-02-25 | |
| 2023-09-30 | -$25.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$25.79M derived: sum of 2 quarters · filed 2024-11-07 | -$33.68M 10-Q · filed 2024-11-07 | $2.24M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-06-30 | -$434.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$8.32M 10-Q · filed 2024-08-08 | $27.59M derived: sum of 3 quarters · filed 2025-02-27 | $33.32M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-03-31 | -$7.89M 10-Q · filed 2024-05-09 | $28.03M derived: sum of 2 quarters · filed 2025-02-27 | $33.76M derived: sum of 3 quarters · filed 2025-02-27 | $41.59M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2022-12-31 | $35.92M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $41.65M derived: sum of 2 quarters · filed 2025-02-27 | $49.48M derived: sum of 3 quarters · filed 2025-02-27 | $52.79M 10-K · filed 2025-02-27 | |
| 2022-09-30 | $5.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $13.56M derived: sum of 2 quarters · filed 2023-11-08 | $16.87M 10-Q · filed 2023-11-08 | $47.51M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-06-30 | $7.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $11.14M 10-Q · filed 2023-08-09 | $41.78M derived: sum of 3 quarters · filed 2024-02-28 | $27.57M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-03-31 | $3.31M 10-Q · filed 2023-05-10 | $33.94M derived: sum of 2 quarters · filed 2024-02-28 | $19.73M derived: sum of 3 quarters · filed 2024-02-28 | $2.82M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2021-12-31 | $30.64M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $16.43M derived: sum of 2 quarters · filed 2024-02-28 | -$489.00K derived: sum of 3 quarters · filed 2024-02-28 | $9.42M 10-K · filed 2024-02-28 | |
| 2021-09-30 | -$14.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$31.12M derived: sum of 2 quarters · filed 2022-11-09 | -$21.21M 10-Q · filed 2022-11-09 | -$17.05M derived: sum of 4 quarters · filed 2023-03-09 | |
| 2021-06-30 | -$16.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | -$7.01M 10-Q · filed 2022-08-10 | -$2.85M derived: sum of 3 quarters · filed 2023-03-09 | $8.34M derived: sum of 4 quarters · filed 2023-03-09 | |
| 2021-03-31 | $9.91M 10-Q · filed 2022-05-11 | $14.07M derived: sum of 2 quarters · filed 2023-03-09 | $25.26M derived: sum of 3 quarters · filed 2023-03-09 | -$12.06M derived: sum of 4 quarters · filed 2023-03-09 | |
| 2020-12-31 | $4.16M derived: 10-K 9 month − 10-Q 6 month · filed 2023-03-09 | $15.35M derived: sum of 2 quarters · filed 2023-03-09 | -$21.97M 10-K · filed 2023-03-09 | ||
| 2020-09-30 | $11.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-10 | -$26.13M 10-Q · filed 2021-11-10 | |||
| 2020-06-30 | -$37.32M 10-Q · filed 2021-08-12 | ||||
| 2020-05-14 | $13.44M 10-K · filed 2023-03-09 | ||||
| 2019-12-31 | $17.05M 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |